Mekinist FDA Approved Drugs
MEKINIST [Trametinib Dimethyl SulfoxideC26H23FIN5O4C2H6OS]
RX
- eq 0.5mg (oral tablet)
eq 1mg (oral tablet)
eq 2mg (oral tablet)
Novartis Pharms CorpMay 29, 2013
- In combination with dabrafenib for the treatment of unresectable or metastatic melanoma..
- Mekenist in combination with dabrafenib for the treatment of patients with unresectable or metastatic melanoma.
- Treatment of unresectable or metastatic melanoma.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.